{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:45:18Z","timestamp":1793036718731,"version":"4.5.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1097\/aog.0b013e3182839fda","type":"journal-article","created":{"date-parts":[[2013,2,6]],"date-time":"2013-02-06T15:19:49Z","timestamp":1360163989000},"page":"607-613","source":"Crossref","is-referenced-by-count":23,"title":["Medical Abortion Follow-up With Serum Human Chorionic Gonadotropin Compared With Ultrasonography"],"prefix":"10.1097","volume":"121","author":[{"given":"Ila","family":"Dayananda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Fortin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa B.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-17-20210126","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2307\/3097714","article-title":"Mifepristone for early medical abortion: experiences in France, Great Britain and Sweden.","volume":"34","author":"Jones","year":"2002","journal-title":"Perspect Sex Reprod Health"},{"key":"R3-17-20210126","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1363\/4304111","article-title":"Abortion incidence and access to services in the United States, 2008.","volume":"43","author":"Jones","year":"2011","journal-title":"Perspect Sex Reprod Health"},{"key":"R4-17-20210126","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0010-7824(96)00274-0","article-title":"Choosing between surgical abortions and medical abortions induced with methotrexate and misoprostol.","volume":"55","author":"Wiebe","year":"1997","journal-title":"Contraception"},{"key":"R5-17-20210126","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1067\/mob.2000.107950","article-title":"Abortion with mifepristone and misoprostol: regimens, efficacy, acceptability and future directions.","volume":"183","author":"Newhall","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"R6-17-20210126","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/01.AOG.0000124782.69622.48","article-title":"Ultrasound evaluation of the endometrium after medical termination of pregnancy.","volume":"103","author":"Cowett","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R7-17-20210126","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/uog.6404","article-title":"Endometrial thickness following medical abortion is not predictive of subsequent surgical intervention.","volume":"34","author":"Reeves","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R8-17-20210126","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/AOG.0b013e3181c996f3","article-title":"Alternatives to a routine follow-up visit for early medical abortion.","volume":"115","author":"Clark","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R9-17-20210126","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.contraception.2009.08.008","article-title":"Feasibility of telephone follow-up after medical abortion.","volume":"81","author":"Perriera","year":"2010","journal-title":"Contraception"},{"key":"R10-17-20210126","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.contraception.2010.08.023","article-title":"Alternatives to ultrasound for follow-up after medication abortion: a systematic review.","volume":"83","author":"Grossman","year":"2011","journal-title":"Contraception"},{"key":"R11-17-20210126","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.contraception.2011.11.010","article-title":"Telephone follow-up and self-performed urine pregnancy testing after early medical abortion: a service evaluation.","volume":"86","author":"Cameron","year":"2012","journal-title":"Contraception"},{"key":"R12-17-20210126","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0301-2115(03)00012-5","article-title":"Verifying the effectiveness of medical abortion; ultrasound versus hCG testing.","volume":"109","author":"Fiala","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R13-17-20210126","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1080\/13625180701536300","article-title":"Medical abortion in the first trimester: the use of serum hCG and endometrial thickness as markers of completeness.","volume":"12","author":"Parashar","year":"2007","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R14-17-20210126","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S1028-4559(09)60190-X","article-title":"Monitoring medical abortion using mifepristonemisoprostol combination with ultrasonogram and serum human chorionic gonadotropin.","volume":"45","author":"Chou","year":"2006","journal-title":"Taiwan J Obstet Gynecol"},{"key":"R15-17-20210126","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0010-7824(01)00266-9","article-title":"Monitoring serum chorionic gonadotropin levels after mifepristone abortion.","volume":"64","author":"Walker","year":"2001","journal-title":"Contraception"},{"key":"R16-17-20210126","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.contraception.2006.11.011","article-title":"Can mifepristone medical abortion be simplified A review of the evidence and questions for future research.","volume":"75","author":"Clark","year":"2007","journal-title":"Contraception"},{"key":"R17-17-20210126","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.contraception.2006.08.001","article-title":"Medication abortion employing routine sequential measurements of serum hCG and sonography only when indicated.","volume":"75","author":"Clark","year":"2007","journal-title":"Contraception"},{"key":"R18-17-20210126","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.contraception.2011.09.007","article-title":"Comparison of medical abortion follow-up with serum human chorionic gonadotropin testing and in-office assessment.","volume":"85","author":"Horning","year":"2012","journal-title":"Contraception"},{"key":"R19-17-20210126","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.contraception.2007.04.008","article-title":"Accuracy of a semi-quantitative urine pregnancy test compared to serum beta-hCG measurement: a possible screening tool for ongoing pregnancy after medication abortion.","volume":"76","author":"Grossman","year":"2007","journal-title":"Contraception"}],"container-title":["Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0b013e3182839fda","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T22:53:28Z","timestamp":1620946408000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201303000-00017"}},"subtitle":["A Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0b013e3182839fda","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}